|
|
Volumn 3, Issue 3, 2004, Pages 238-
|
|
Highlighting the pitfalls and possibilities of drug research
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CALCIUM CHANNEL;
CALCIUM ION;
CAPTOPRIL;
CARBAMAZEPINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DIZOCILPINE;
ETANERCEPT;
INFLIXIMAB;
ION CHANNEL;
LISINOPRIL;
PERTUZUMAB;
PHENYTOIN;
POTASSIUM CHANNEL;
POTASSIUM ION;
SNAKE VENOM;
SODIUM CHANNEL;
SODIUM ION;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
VERAPAMIL;
AMINO ACID SEQUENCE;
ANTIINFLAMMATORY ACTIVITY;
BREAST TUMOR;
CARDIOVASCULAR DISEASE;
CHANNEL GATING;
CLINICAL TRIAL;
CROHN DISEASE;
DRUG DISTRIBUTION;
DRUG RESEARCH;
DRUG STRUCTURE;
EDITORIAL;
ELECTRON SPIN RESONANCE;
ELECTROPHYSIOLOGY;
EPILEPSY;
FLUORESCENCE RESONANCE ENERGY TRANSFER;
GENE EXPRESSION PROFILING;
GENE SEQUENCE;
GENOTYPE;
HUMAN;
MASS SPECTROMETRY;
MEDICAL TECHNOLOGY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE;
PHENOTYPE;
PRIORITY JOURNAL;
PROSTATE TUMOR;
PROTEIN MICROARRAY;
PROTEOMICS;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
RHEUMATOID ARTHRITIS;
STRUCTURE ACTIVITY RELATION;
X RAY CRYSTALLOGRAPHY;
|
|
EID: 1642365102
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1332 Document Type: Editorial |
|
Times cited : (16)
|
|
References (0)
|